Skip to Main Content

Author Details

Song Yi
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
2006
52
29
Gloria M Sheynkman (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
33855356mi-IsoNet: systems-scale microRNA landscape reveals rampant isoform-mediated gain of target interaction diversity and signaling specificity.Brief Bioinform2021
29738884Pathway perturbations in signaling networks: Linking genotype to phenotype.Semin Cell Dev Biol2020
32855206Integrated Genomic Characterization of the Human Immunome in Cancer.Cancer Res2020
29077860Systematic review of computational methods for identifying miRNA-mediated RNA-RNA crosstalk.Brief Bioinform2019
30153342MERIT: Systematic Analysis and Characterization of Mutational Effect on RNA Interactome Topology.Hepatology2019
31214618Laboratory and Clinical Evaluation of DNA Microarray for the Detection of Carbapenemase Genes in Gram-Negative Bacteria from Hospitalized Patients.Biomed Res Int2019
31047772Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology.Trends Biochem Sci2019
30679789Correction: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.Oncogene2019
29325141LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations.Nucleic Acids Res2018
29941230Gene Regulatory Network Perturbation by Genetic and Epigenetic Variation.Trends Biochem Sci2018
29855617Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.Oncogene2018
30254371Polycomb Repressive Complex 2 is essential for development and maintenance of a functional TEC compartment.Sci Rep2018
30417219Combined immunomagnetic capture coupled with ultrasensitive plasmonic detection of circulating tumor cells in blood.Biomed Microdevices2018
30276203Microarray-Based Detection and Clinical Evaluation for <i>Helicobacter pylori</i> Resistance to Clarithromycin or Levofloxacin and the Genotype of CYP2C19 in 1083 Patients.Biomed Res Int2018
29388456Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis.Crit Rev Clin Lab Sci2018
29615613Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers.Nat Commun2018
29533785Systematic Functional Annotation of Somatic Mutations in Cancer.Cancer Cell2018
29312578Integrated analysis of chromosome copy number variation and gene expression in cervical carcinoma.Oncotarget2017
28131823In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons.Cell Syst2017
28215707HSP90 Shapes the Consequences of Human Genetic Variation.Cell2017
28422313Regulome networks and mutational landscape in liver cancer: An informative path to precision medicine.Hepatology2017
28344341Functional variomics and network perturbation: connecting genotype to phenotype in cancer.Nat Rev Genet2017
28981122Base-resolution stratification of cancer mutations using functional variomics.Nat Protoc2017
29045845Revealing the Determinants of Widespread Alternative Splicing Perturbation in Cancer.Cell Rep2017
26871637Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.Cell2016
27791983Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.Oncotarget2016
27525280Signal Transduction and Regulation: Insights into Evolution.Biomed Res Int2016
27403431Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks.Biomed Res Int2016
27013732Survey of variation in human transcription factors reveals prevalent DNA binding changes.Science2016
27107012Pooled-matrix protein interaction screens using Barcode Fusion Genetics.Mol Syst Biol2016
26975778An extended set of yeast-based functional assays accurately identifies human disease mutations.Genome Res2016
25910213Human gene-centered transcription factor networks for enhancers and disease variants.Cell2015
25910212Widespread macromolecular interaction perturbations in human genetic disorders.Cell2015
24722188Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism.Nat Commun2014
25416956A proteome-scale map of the human interactome network.Cell2014
25484572Computational advances in cancer informatics (a).Cancer Inform2014
24287335Edgotype: a fundamental link between genotype and phenotype.Curr Opin Genet Dev2013
22253594Nonsex genes in the mating type locus of Candida albicans play roles in a/α biofilm formation, including impermeability and fluconazole resistance.PLoS Pathog2012
21221248Utilization of the mating scaffold protein in the evolution of a new signal transduction pathway for biofilm development.mBio2011
21829325Alternative mating type configurations (a/α versus a/a or α/α) of Candida albicans result in alternative biofilms regulated by different pathways.PLoS Biol2011
21498642Self-induction of a/a or alpha/alpha biofilms in Candida albicans is a pheromone-based paracrine system requiring switching.Eukaryot Cell2011
20300604N-acetylglucosamine induces white to opaque switching, a mating prerequisite in Candida albicans.PLoS Pathog2010
20454615Tec1 mediates the pheromone response of the white phenotype of Candida albicans: insights into the evolution of new signal transduction pathways.PLoS Biol2010
19200725CO(2) regulates white-to-opaque switching in Candida albicans.Curr Biol2009
19798425Genes selectively up-regulated by pheromone in white cells are involved in biofilm formation in Candida albicans.PLoS Pathog2009
19170873A Candida albicans-specific region of the alpha-pheromone receptor plays a selective role in the white cell pheromone response.Mol Microbiol2009
19074600The white cell response to pheromone is a general characteristic of Candida albicans strains.Eukaryot Cell2009
18162580The same receptor, G protein, and mitogen-activated protein kinase pathway activate different downstream regulators in the alternative white and opaque pheromone responses of Candida albicans.Mol Biol Cell2008
18957584Dark brown is the more virulent of the switch phenotypes of Candida glabrata.Microbiology (Reading)2008
16215989Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.J Cell Biochem2006
  • 1 - 50 of 52

Recommended Authors

Arthur Wuster
Genentech Inc.
Career Start Year 2008
Number of shared co-authors 2
Kahn Rhrissorrakrai
T.J. Watson Research Center
Career Start Year 2008
Number of shared co-authors 5
Katherine Licon
University of California San Diego
Career Start Year 2008
Number of shared co-authors 2
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 3
Xiaotu Ma
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 3
Christopher L Plaisier
Arizona State University
Career Start Year 2005
Number of shared co-authors 3
Semin Lee
Ulsan National Institute of Science and Technology (UNIST)
Career Start Year 2005
Number of shared co-authors 10
Shannan J Ho Sui
Harvard T.H. Chan School of Public Health
Career Start Year 2004
Number of shared co-authors 1
Ted Laderas
Oregon Health & Science University
Career Start Year 2003
Number of shared co-authors 0
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 5
Chen-Hsiang Yeang
Institute of Statistical Science
Career Start Year 2001
Number of shared co-authors 1
Gary D Bader
University of Toronto
Career Start Year 2000
Number of shared co-authors 19
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 3
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 1
Zhongming Zhao
Center for Precision Health, The University of Texas Health Science Center at Houston
Career Start Year 1998
Number of shared co-authors 8
Igor Jurisica
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 5
Nevan J Krogan (CM4AI)
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 18
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 4
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Career Start Year 1997
Number of shared co-authors 1
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 0
Trey Ideker (CM4AI)
University of California San Diego
Career Start Year 1996
Number of shared co-authors 16
Steven J M Jones
University of British Columbia
Career Start Year 1995
Number of shared co-authors 11
Wolfgang Huber
Technische Universitat Munchen
Career Start Year 1995
Number of shared co-authors 4
Joel S Bader
Johns Hopkins University
Career Start Year 1993
Number of shared co-authors 8
Andrea Califano
Columbia University
Career Start Year 1993
Number of shared co-authors 5
Zugen Chen
David Geffen School of Medicine, University of California los angeles
Career Start Year 1992
Number of shared co-authors 2
Jill P Mesirov
University of California San Diego
Career Start Year 1992
Number of shared co-authors 6
John Quackenbush
Harvard T. H. Chan School of Public Health
Career Start Year 1989
Number of shared co-authors 7
Michael F Ochs
The College of New Jersey
Career Start Year 1988
Number of shared co-authors 1
David A Wheeler
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 19

Collaborators

Nidhi Sahni
The University of Texas MD Anderson Cancer Center
Co-authored papers 37
Yongsheng Li
Harbin Medical University
Co-authored papers 13
Marc Vidal
Blavatnik Institute, Harvard Medical School
Co-authored papers 11
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 7
Juan Xu
College of Bioinformatics Science and Technology, Harbin Medical University
Co-authored papers 6
Frederick P Roth
University of Toronto
Co-authored papers 6
Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Co-authored papers 6
Jasmin Coulombe-Huntington
Institute for Research in Immunology and Cancer, Universite de Montreal
Co-authored papers 4
Yu Xia
College of Information Engineering, Zhejiang University of Technology
Co-authored papers 3
Patrick Aloy
Institucio Catalana de Recerca i Estudis Avancats (ICREA)
Co-authored papers 3
Susan Lindquist
Whitehead Institute for Biomedical Research
Co-authored papers 3
Shiaw-Yih Lin
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Xiaoqian Jiang
Carnegie Mellon University, The University of Texas Health Science Center at Houston, University of California San Diego
Co-authored papers 3
Luke Whitesell
University of Toronto
Co-authored papers 2
Atanas Kamburov
Broad Institute of Harvard and MIT
Co-authored papers 2
Yiling Lu
Co-authored papers 2
Kerstin Spirohn
Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute
Co-authored papers 2
Limei Hu
Aier Eye Hospital of Wuhan University
Co-authored papers 2
Rita Pancsa
Institute of Enzymology, HUN-REN Research Centre for Natural Sciences
Co-authored papers 2
Albert-L??szl?? Barab??si
Network Science Institute, Northeastern University
Co-authored papers 2
Shengda Lin
Life Sciences Institute, Zhejiang University
Co-authored papers 2
Madan Mohan Babu
St. Jude Children's Research Hospital
Co-authored papers 2
Michael Costanzo
Co-authored papers 2
Nozomu Yachie
The University of British Columbia
Co-authored papers 2
Brenda J Andrews
University of Toronto
Co-authored papers 2
Charles Boone
University of Toronto
Co-authored papers 2
Mark Gerstein
Yale University
Co-authored papers 1
Zhenlin Ju
Co-authored papers 1
Han Liang
MD Anderson Cancer Center
Co-authored papers 1
Pavan K Auluck
Co-authored papers 1
Release 1.2